Gene: EEIG1
Official Full Name: estrogen-induced osteoclastogenesis regulator 1provided by HGNC
Gene Summary: Predicted to be involved in positive regulation of osteoclast differentiation. Predicted to be located in cytoplasm; membrane raft; and nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18066 | EEIG1 Knockout cell line (HeLa) | Human | EEIG1 | 1:3~1:6 | Negative | Online Inquiry |
KO18067 | EEIG1 Knockout cell line (HCT 116) | Human | EEIG1 | 1:2~1:4 | Negative | Online Inquiry |
KO18068 | EEIG1 Knockout cell line (HEK293) | Human | EEIG1 | 1:3~1:6 | Negative | Online Inquiry |
KO18069 | EEIG1 Knockout cell line (A549) | Human | EEIG1 | 1:3~1:4 | Negative | Online Inquiry |
EEIG1 Gene Knockout Cell Lines are precisely engineered cellular models designed to facilitate the study of the EEIG1 gene, which is implicated in various biological processes and diseases. These knockout cell lines are created using advanced CRISPR/Cas9 technology, effectively disabling the EEIG1 gene, thereby allowing researchers to investigate the gene's function and its role in cellular mechanisms.
The primary function of EEIG1 Gene Knockout Cell Lines is to provide a robust platform for studying gene activity and its consequences on cellular behavior. By knocking out the EEIG1 gene, researchers can analyze changes in cellular proliferation, apoptosis, and other biochemical pathways, elucidating the gene's contribution to normal physiology and disease states. This is particularly valuable in cancer research, where the EEIG1 gene has been linked to tumor progression and metastasis.
The scientific importance of these cell lines lies in their versatile applications in fundamental research and translational medicine. They serve as critical tools for drug discovery, biomarker development, and therapeutic interventions targeting diseases associated with aberrations in EEIG1 expression. These knockout models can also support investigations into genetic interactions and compensatory mechanisms within cellular systems.
One of the unique selling points of our EEIG1 Gene Knockout Cell Lines is their reliable and consistent performance, backed by comprehensive validation studies that confirm the complete knockout of the target gene. Compared to conventional methods like RNA interference, CRISPR/Cas9 knockout provides a more permanent solution, which is essential for long-term studies and applications in drug development.
For researchers and clinicians, the EEIG1 Gene Knockout Cell Lines represent an invaluable resource. They not only enable deeper understanding of gene function but also significantly accelerate the pace at which novel therapeutic strategies can be developed. The ability to observe the biological effects of gene manipulation in a controlled environment allows for expedited hypothesis testing and validation.
Our company is committed to advancing biological research by offering high-quality, state-of-the-art genetic tools. With extensive experience in the field of molecular biology and gene editing, we are dedicated to providing products that meet the highest scientific standards, supporting researchers in their quest for groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.